drugset
drugset / Trial / NCT04194710

Arthroscopic Debridement Versus Autologous Cytokine Rich Serum for the Treatment of Lateral Epicondylitis

NCT04194710 ↗

Unknown 86 enrolled Corporacion Parc Tauli Tecnologia Regenerativa Qrem S.L. · collab
RandomizedParallel-groupSingle-blindTreatment

Summary

This study aims to compare arthroscopic resection (surgical intervention) versus infiltration of cytokine rich serum (CRS) (proteins derived from the patient's own blood) for the treatment of lateral epicondylitis (LE).

Timeline

Start
2020-12-22
Primary completion
2023-07-01
Completion
2023-12-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Autologous Cytokine Rich Serum Protein / enzyme biologic — Other

Indications

epicondylitis